Download PDF
Semin Neurol 2002; 22(2): 133-142
DOI: 10.1055/s-2002-36536
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Infectious Myelopathies

Joseph R. Berger1,2 , Arman Sabet1
  • 1Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky
  • 2Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky
Further Information

Publication History

Publication Date:
13 January 2003 (online)

    Permissions and Reprints

ABSTRACT

Although infectious myelopathies are rare, timely and accurate diagnosis is essential to improving outcome. There are a number of organisms that may cause infectious myelopathies, including human immunodeficiency virus (HIV), human T-cell lymphotropic virus type I (HTLV-I), herpesviruses, enteroviruses, Treponema pallidum, Mycobacterium tuberculosis, fungi, and parasites. Vacuolar myelopathy, the most common form of spinal cord disease in HIV-infected individuals, is underrecognized clinically. The failure to diagnose this condition is generally a consequence of the attribution of the lower extremity weakness and paresthesias to general debility and concomitant peripheral neuropathy. Tropical spastic paraparesis or HTLV-I-associated myelopathy involves the pyramidal tracts, chiefly at the thoracic level, and results in spastic lower extremity weakness and a spastic bladder. The herpesviruses (varicella-zoster, herpes simplex type 2, cytomegalovirus) and the enteroviruses cause myelitis. Prior to the development of antibiotics, syphilis was the most frequent infectious cause of spinal cord disease. In light of the broad spectrum of pathogens that may affect the spinal cord and the variegate fashion in which these disorders may present, the physician must always consider an infectious etiology in the differential diagnosis for the patient presenting with myelopathy. This review addresses the infectious myelopathies by microorganism.

KEYWORDS

AIDS - HIV-associated vacuolar myelopathy - HTLV-I-associated myelopathy - cytomegalovirus - varicella-zoster virus - tuberculosis - syphilis - tabes dorsalis - schistosomiasis only those hours of credit that he/she actually spent in the educational activity.

REFERENCES

  • 1 Bhigjee A I, Madurai S, Bill P L. Spectrum of myelopathies in HIV seropositive South African patients.  Neurology . 2001;  57 348-351
    PubMedGoogle Scholar
  • 2 Petito C K, Navia B A, Cho E S, Jordan B D, George D C, Price R W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome.  N Engl J Med . 1985;  312 874-879
    PubMedGoogle Scholar
  • 3 Levy R M, Bredesen D E, Rosenblum M L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.  J Neurosurg . 1985;  62 475-495
    CrossrefPubMedGoogle Scholar
  • 4 Helweg-Larsen S, Jakobsen J, Boesen F, Arlien-Soborg P. Neurological complications and concomitants of AIDS.  Acta Neurol Scand . 1986;  74 467-474
    PubMedGoogle Scholar
  • 5 de la Monte M S, Ho D D, Schooley R T, Hirsch M S, Richardson Jr P E. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection.  Neurology . 1987;  37 562-569
    PubMedGoogle Scholar
  • 6 Di Rocco A. Diseases of the spinal cord in human immunodeficiency virus infection.  Semin Neurol . 1999;  19 151-155
    PubMedGoogle Scholar
  • 7 Tagliati M, Di Rocco A, Danisi F, Simpson D M. The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy.  Neurology . 2000;  54 1477-1482
    PubMedGoogle Scholar
  • 8 Honig L, Vogel H, Horoupian D. Chronic myelopathy as a presenting symptom in HIV infection [abstract].  Neurology . 1989;  39(suppl 1) 419
    PubMedGoogle Scholar
  • 9 Goldstick L, Mandybur T I, Bode R. Spinal cord degeneration in AIDS.  Neurology . 1985;  35 10310-10316
    PubMedGoogle Scholar
  • 10 Shepherd E J, Brettle R P, Liberski P P. Spinal cord pathology and viral burden in homosexuals and drug users with AIDS.  Neuropathol Appl Neurobiol . 1999;  25 2-10
    PubMedGoogle Scholar
  • 11 Kamin S S, Petito C K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients.  Hum Pathol . 1991;  22 816-824
    CrossrefPubMedGoogle Scholar
  • 12 Singh B M, Levine S, Yarrish R L, Hyland M J, Jeanty D, Wormser G P. Spinal cord syndromes in the acquired immune deficiency syndrome.  Acta Neurol Scand . 1986;  73 590-598
    PubMedGoogle Scholar
  • 13 Di Rocco A, Simpson D M. AIDS-associated vacuolar myelopathy.  AIDS Patient Care STDS . 1998;  12 457-461
    CrossrefPubMedGoogle Scholar
  • 14 Tan S V, Guiloff R J. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.  J Neurol Neurosurg Psychiatry . 1998;  65 23-28
    CrossrefPubMedGoogle Scholar
  • 15 Dickson D W, Belman A L, Kim T S, Horoupian D S, Rubinstein A. Spinal cord pathology in pediatric acquired immunodeficiency syndrome.  Neurology . 1989;  39 227-235
    PubMedGoogle Scholar
  • 16 Geraci A, Di Rocco A, Liu M. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid.  Neurology . 2000;  55 440-442
    PubMedGoogle Scholar
  • 17 Denning D W, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus.  Br Med J (Clin Res Ed) . 1987;  294 143-144
    PubMedGoogle Scholar
  • 18 Narciso P, Galgani S, Del Grosso B. Acute disseminated encephalomyelitis as manifestation of primary HIV infection.  Neurology . 2001;  57 1493-1496
    PubMedGoogle Scholar
  • 19 Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy.  Neurology . 2000;  54 267-268
    PubMedGoogle Scholar
  • 20 Williams A E, Fang C T, Slamon D J. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.  Science . 1988;  240 643-646
    PubMedGoogle Scholar
  • 21 Robert-Guroff M, Weiss S, Giron J. Prevalence of antibodies to HTLV-1, -II, and -III in intravenous drug abusers from an AIDS endemic region.  JAMA . 1986;  255 3133-3137
    CrossrefPubMedGoogle Scholar
  • 22 Khabbaz R F, Darrow W W, Hartley T M. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States.  JAMA . 1990;  263 60-64
    CrossrefPubMedGoogle Scholar
  • 23 Sheremata W A, Berger J R, Harrington Jr J W, Ayyar D R, Stafford M, DeFreitas E. Human T lymphotropic virus type I-associated myelopathy: a report of 10 patients born in the United States.  Arch Neurol . 1992;  49 1113-1118
    PubMedGoogle Scholar
  • 24 Gotuzzo E, Arango C, de Queiroz-Campos A, Isturiz R E. Human T-cell lymphotropic virus-I in Latin America.  Infect Dis Clin North Am . 2000;  14 211-239
    CrossrefPubMedGoogle Scholar
  • 25 Gessain A, Barin F, Vernant J C. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.  Lancet . 1985;  2 407-410
    PubMedGoogle Scholar
  • 26 Osame M, Usuku K, Izumo S. HTLV-I associated myelopathy, a new clinical entity.  Lancet . 1986;  1 1031-1032
    PubMedGoogle Scholar
  • 27 Vernant J C, Maurs L, Gessain A. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases.  Ann Neurol . 1987;  21 123-130
    CrossrefPubMedGoogle Scholar
  • 28 Akizuki S, Nakazato O, Higuchi Y. Necropsy findings in HTLV-I associated myelopathy.  Lancet . 1987;  1 156-157
    PubMedGoogle Scholar
  • 29 Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy.  Neuropathology . 2000;  20(suppl) S65-S68
    PubMedGoogle Scholar
  • 30 Castillo L C, Gracia F, Roman G C, Levine P, Reeves W C, Kaplan J. Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/ HTLV-II): report of 3 cases from Panama.  Acta Neurol Scand . 2000;  101 405-412
    CrossrefPubMedGoogle Scholar
  • 31 Zehender G, De Maddalena C, Osio M. High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1-associated predominantly sensory polyneuropathy.  J Infect Dis . 1995;  172 1595-1598
    PubMedGoogle Scholar
  • 32 Mitsui Y, Kusunoki S, Hiruma S. Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection.  Muscle Nerve . 1999;  22 1461-1465
    PubMedGoogle Scholar
  • 33 Smith C R, Dickson D, Samkoff L. Recurrent encephalopathy and seizures in a US native with HTLV-I-associated myelopathy/tropical spastic paraparesis: a clinicopathologic study.  Neurology . 1992;  42 658-661
    PubMedGoogle Scholar
  • 34 Nagai M, Yamano Y, Brennan M B, Mora C A, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.  Ann Neurol . 2001;  50 807-812
    CrossrefPubMedGoogle Scholar
  • 35 Berger J R. PML in AIDS.  Neurology . 1992;  42 1845-1846
    PubMedGoogle Scholar
  • 36 Lehky T J, Flerlage N, Katz D. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.  Ann Neurol . 1996;  40 714-723
    CrossrefPubMedGoogle Scholar
  • 37 Puccioni-Sohler M, Rios M, Carvalho S M. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index.  Neurology . 2001;  57 725-727
    PubMedGoogle Scholar
  • 38 Nakagawa M, Nakahara K, Maruyama Y. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.  J Neurovirol . 1996;  2 345-355
    CrossrefPubMedGoogle Scholar
  • 39 Stambos V, Brussen K A, Turnbull A, Thorley B, Kennett M. Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000.  Commun Dis Intell . 2001;  25 54-58
    PubMedGoogle Scholar
  • 40 Rose F, Brett E, Burton J. Zoster encephalomyelitis.  Arch Neurol . 1964;  11 155
    PubMedGoogle Scholar
  • 41 Baik J S, Kim W C, Heo J H, Zheng H Y. Recurrent herpes zoster myelitis.  J Korean Med Sci . 1997;  12 360-363
    PubMedGoogle Scholar
  • 42 Kleinschmidt-DeMasters B K, Gilden D H. The expanding spectrum of herpesvirus infections of the nervous system.  Brain Pathol . 2001;  11 440-451
    PubMedGoogle Scholar
  • 43 de Silva M S, Mark A S, Gilden D H. Zoster myelitis: improvement with antiviral therapy in two cases.  Neurology . 1996;  47 929-931
    PubMedGoogle Scholar
  • 44 Caplan L R, Kleeman F J, Berg S. Urinary retention probably secondary to herpes genitalis.  N Engl J Med . 1977;  297 920-921
    PubMedGoogle Scholar
  • 45 Klastersky J, Capperl R, Snoeck J M. Ascending myelitis in association with herpes simplex virus.  N Engl J Med . 1982;  287 182
    PubMedGoogle Scholar
  • 46 Grose C, Feorino P M. Epstein-Barr virus and transverse myelitis.  Lancet . 1973;  1 892
    PubMedGoogle Scholar
  • 47 Silverstein A. Epstein-Barr virus infections of the nervous system. In: Vinken P, Bruyn G, eds. Infections of the Nervous System Amsterdam: North Holland 1978: 185-192
    Google Scholar
  • 48 Tyler K L, Gross R A, Cascino G D. Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus.  Neurology . 1986;  36 855-858
    CrossrefPubMedGoogle Scholar
  • 49 Paine R, Byers R. Transverse myelopathy in childhood.  Am J Child . 1953;  85 151
    PubMedGoogle Scholar
  • 50 Altrocchi P. Acute transverse myelopathy.  Arch Neurol . 1963;  9 111
    CrossrefPubMedGoogle Scholar
  • 51 Lipton H L, Teasdall R D. Acute transverse myelopathy in adults: a follow-up study.  Arch Neurol . 1973;  28 252-257
    PubMedGoogle Scholar
  • 52 Ropper A H, Poskanzer D C. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms.  Ann Neurol . 1978;  4 51-59
    CrossrefPubMedGoogle Scholar
  • 53 Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations.  Neurology . 1981;  31 966-971
    CrossrefPubMedGoogle Scholar
  • 54 Berger J. Syphilis of the spinal cord. In: Davidoff RA, ed. Handbook of the Spinal Cord New York: Marcel Dekker 1987: 491-538
    Google Scholar
  • 55 Berger J R, Moskowitz L, Fischl M, Kelley R E. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome.  South Med J . 1987;  80 683-686
    CrossrefPubMedGoogle Scholar
  • 56 Fisher M, Poser C M. Syphilitic meningomyelitis: a case report.  Arch Neurol . 1977;  34 785
    PubMedGoogle Scholar
  • 57 Gribble L D. Syphilitic spinal pachymeningitis.  S Afr Med J . 1972;  46 1326-1328
    PubMedGoogle Scholar
  • 58 Centers for Disease Control. Recommended treatment schedules, 1976.  Ann Intern Med . 1976;  85 94
    PubMedGoogle Scholar
  • 59 Berger J. Neurosyphilis. In: Johnson R, ed. Current Therapies in Neurology Philadelphia: BC Dekker 1990: 143-148
    Google Scholar
  • 60 Griffiths D L. Tuberculosis of the spine: a review.  Adv Tuberc Res . 1980;  20 92-110
    PubMedGoogle Scholar
  • 61 Nussbaum E S, Rockswold G L, Bergman T A, Erickson D L, Seljeskog E L. Spinal tuberculosis: a diagnostic and management challenge.  J Neurosurg . 1995;  83 243-247
    CrossrefPubMedGoogle Scholar
  • 62 Kim S W, Kim R C, Choi B H, Gordon S K. Non-traumatic ischaemic myelopathy: a review of 25 cases.  Paraplegia . 1988;  26 262-272
    PubMedGoogle Scholar
  • 63 Kaynar M Y, Kocer N, Gencosmanoglu B E, Hanci M. Syringomyelia: as a late complication of tuberculous meningitis.  Acta Neurochir . 2000;  142 935-938
    CrossrefPubMedGoogle Scholar
  • 64 White V L, Al-Shahi R, Gamble E, Brown P, Davison A G. Transverse myelopathy and radiculomyelopathy associated with pulmonary atypical Mycobacterium infections.  Thorax . 2001;  56 158-160
    CrossrefPubMedGoogle Scholar
  • 65 Moon M S, Ha K Y, Sun D H, Moon J L, Moon Y W, Chung J H. Pott's paraplegia: 67 cases.  Clin Orthop . 1996;  323 122-128
    PubMedGoogle Scholar
  • 66 Vidyasagar C, Murthy H K. Spinal tuberculosis with neurological deficits.  Natl Med J India . 1996;  9 25-27
    PubMedGoogle Scholar
  • 67 Dutton J, Alexander G. Intramedullary spinal abscess.  J Neurol Neurosurg Psychiatry . 1954;  17 303
    PubMedGoogle Scholar
  • 68 Miller H, Stanton J, Gibbons J. Parainfectious encephalomyelitis and related syndromes: a critical review of the neurologic complications of certain specific fevers.  J Med . 1956;  25 427
    PubMedGoogle Scholar
  • 69 Kincaid J, Dyken M. Myelitis and myelopathy. In: Baker A, Baker L, eds. Clinical Neurology New York: Harper & Row 1982: 1-31
    Google Scholar
  • 70 Pickeritt R, Milder J. Transverse myelitis associated with cat-scratch disease in an adult.  JAMA . 1981;  246 2840-2841
    CrossrefPubMedGoogle Scholar
  • 71 Reik L, Steere A C, Bartenhagen N H, Shope R E, Malawista S E. Neurologic abnormalities of Lyme disease.  Medicine (Baltimore) . 1979;  58 281-294
    CrossrefPubMedGoogle Scholar
  • 72 Gumbo T, Hakim J G, Mielke J, Siwji S, Just-Nubling G, Ismail A. Cryptococcus myelitis: atypical presentation of a common infection.  Clin Infect Dis . 2001;  32 1235-1236
    CrossrefPubMedGoogle Scholar
  • 73 Koh S, Ross L A, Gilles F H, Nelson Jr D M, Mitchell W G. Myelopathy resulting from invasive aspergillosis.  Pediatr Neurol . 1998;  19 135-138
    CrossrefPubMedGoogle Scholar
  • 74 Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients.  Neurosurg Rev . 2000;  23 175-205
    CrossrefPubMedGoogle Scholar
  • 75 Kaufman D M, Kaplan J G, Litman N. Infectious agents in spinal epidural abscesses.  Neurology . 1980;  30 844-850
    CrossrefPubMedGoogle Scholar
  • 76 Baker A, Ojemann R, Swartz M, Richardson Jr P E. Spinal epidural abscess.  N Engl J Med . 1975;  293 463-468
    PubMedGoogle Scholar
      >